Correction to: HER2-directed antibodies, affibodies and nanobodies as drug-delivery vehicles in breast cancer with a specific focus on radioimmunotherapy and radioimmunoimaging (European Journal of Nuclear Medicine and Molecular Imaging, (2021), 48, 5, (1371-1389), 10.1007/s00259-020-05094-1)

The authors regret that there are some errors in the original published article. The below article note should be removed. On the other hand, the “Authors’ contributions” section should be corrected from: Conceptualization, writing—original draft preparation BA, AM; writing—review and editing, all authors. All authors have read and agreed to the published version of the manuscript. to: Conceptualization, writing—original draft preparation BA; writing—review and editing, all authors. All authors have read and agreed to the published version of the manuscript. The original article has been corrected.